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To the Editor, Dr. Li et al. raise several important and interesting questions about our paper, 1, 2 and I appreciate the opportunity to address them. One question was whether we corrected postoperative serum creatinine measures based on the perioperative fluid balance. We did not do so because we have no confidence in the accuracy of the recorded perioperative fluid balance, which has been shown to be an unreliable measure of changes in body weight associated with cardiac surgery. 3 Another question relates to our choice of the 30% early rise in creatinine (the ratio of the postoperative creatinine level to the preoperative creatinine level; DCreat ratio ) as the threshold for early diagnosis of acute kidney injury (AKI) because a smaller threshold of 10% is also predictive of AKI. 4 Our 30% threshold provided the greatest proportion of correctly classified observations and maximized the positive predictive value (which was 69% for the 30% threshold versus 39% for the 10% threshold). Maximizing the positive predictive value is particularly desirable if DCreat ratio is to be used for early identification of patients to include in clinical trials aimed at ameliorating AKI.
Dr. Li et al. correctly state that, by externally validating the relation between DCreat ratio and AKI stage I only (i.e., [ 1.5-fold increase in serum creatinine) -the mildest AKI category of the consensus recommendations of the AKI Network classification 5 -we neglected the more severe and clinically relevant categories of AKI. As there is a direct relation between the severity of AKI after cardiac surgery and adverse clinical outcomes, 6 this point is an important shortcoming. We have now externally validated the relation between DCreat ratio and AKI stages II and III (representing a [ 2.0-fold and [ 3.0-fold increase in serum creatinine, respectively) (Table) .
The final question relates to the predictive value of DCreat ratio relative to existing clinical prediction models, Table Area such as the Cleveland risk score. 7 We measured the relative predictive values of DCreat ratio and the Cleveland risk score in the logistic regression model and found that DCreat ratio had a substantially higher predictive value than the Cleveland risk score (Table 3 of the original paper). In addition, the area under the receiver operating characteristic (AUROC) curve of the model for AKI stage I that included only DCreat ratio was 0.78 (95% confidence interval [CI], 0.75 to 0.80). Substituting DCreat ratio with the Cleveland risk score in the model reduces the AUROC to 0.64 (95% CI, 0.61 to 0.67). It is important to note that the purpose of the Cleveland risk score is to predict renal replacement therapy, not AKI. Nevertheless, it is not surprising that a postoperative variable is more predictive than a score derived from preoperative variables.
